prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |review

Also at the Arthritis Institute, we have a study of 1588 subjects being enrolled in 13 centers asking whether glucosamine or chondroitin sulfate, alone or in combination, are superior to placebo and might be as good as the current main therapy, cyclooxygenase II inhibitors (COX-2).

And with the Cancer Institute, we’re privileged to help support a 32,000 patient study for prevention of prostate cancer with Vitamin E and selenium.

  With the Heart Institute, we are about to award a major multi-center trial for the first time of ETDA chelation therapy for coronary artery disease.  And with the Diabetes Institute we have called for applications to study two of the world’s most popular herbal products for the treatment of prostatic enlargement, which many men in my age begin to consider as a health factor.

 

第三阶段随机控制试验的研究状态:

葡萄胺/软骨素对骨关节的治疗作用               研究中

维生素E/硒对前列腺癌的治疗作用                研究中

EDTACAD的螯合治疗                              授予未决

锯状矮棕榈/对前列腺增生症的治疗作用         已公布